Supporting prescribing in Irish primary care: Protocol for a non-randomised pilot study of a general practice pharmacist (GPP) intervention to optimise prescribing in primary care

被引:14
|
作者
Cardwell K. [1 ]
Clyne B. [1 ]
Moriarty F. [1 ]
Wallace E. [1 ]
Fahey T. [1 ]
Boland F. [1 ]
McCullagh L. [2 ]
Clarke S. [3 ]
Finnigan K. [3 ]
Daly M. [3 ]
Barry M. [2 ,3 ]
Smith S.M. [1 ]
机构
[1] Health Research Board Centre for Primary Care Research, Royal College of Surgeons in Ireland, 123 St Stephen's Green, Dublin
[2] Department of Pharmacology and Therapeutics, Trinity College Dublin, Dublin
[3] Health Service Executive Medicines Management Programme, Dublin
关键词
Irish Primary Care; General Practice Team; Patient-reported Outcome Measures (PROM); Potentially Inappropriate Prescribing (PIP); Significant Polypharmacy;
D O I
10.1186/s40814-018-0311-7
中图分类号
学科分类号
摘要
Background: Prescribing for patients taking multiple medicines (i.e. polypharmacy) is challenging for general practitioners (GPs). Limited evidence suggests that the integration of pharmacists into the general practice team could improve the management of these patients. The aim of this study is to develop and test an intervention involving pharmacists, working within GP practices, to optimise prescribing in Ireland, which has a mixed public and private primary healthcare system. Methods: This non-randomised pilot study will use a mixed-methods approach. Four general practices will be purposively sampled and recruited. A pharmacist will join the practice team for 6 months. They will participate in the management of repeat prescribing and undertake medication reviews (which will address high-risk prescribing and potentially inappropriate prescribing, deprescribing and cost-effective and generic prescribing) with adult patients. Pharmacists will also provide prescribing advice regarding the use of preferred drugs, undertake clinical audits, join practice team meetings and facilitate practice-based education. Throughout the 6-month intervention period, anonymised practice-level medication (e.g. medication changes) and cost data will be collected. A nested Patient Reported Outcome Measure (PROM) study will be undertaken during months 4 and 5 of the 6-month intervention period to explore the impact of the intervention in older adults (aged ≥ 65 years). For this, a sub-set of 50 patients aged ≥ 65 years with significant polypharmacy (≥10 repeat medicines) will be recruited from each practice and invited to a medication review with the pharmacist. PROMs and healthcare utilisation data will be collected using patient questionnaires, and a 6-week follow-up review conducted. Acceptability of the intervention will be explored using pre- and post-intervention semi-structured interviews with key stakeholders. Quantitative and qualitative data analysis will be undertaken and an economic evaluation conducted. Discussion: This non-randomised pilot study will provide evidence regarding the feasibility and potential effectiveness of general practice-based pharmacists in Ireland and provide data on whether a randomised controlled trial of this intervention is indicated. It will also provide a deeper understanding as to how a pharmacist working as part of the general practice team will affect organisational processes and professional relationships in a mixed public and private primary healthcare system. © The Author(s).
引用
收藏
相关论文
共 50 条
  • [1] Evaluation of the General Practice Pharmacist (GPP) intervention to optimise prescribing in Irish primary care: a non-randomised pilot study
    Cardwell, Karen
    Smith, Susan M.
    Clyne, Barbara
    McCullagh, Laura
    Wallace, Emma
    Kirke, Ciara
    Fahey, Tom
    Moriarty, Frank
    [J]. BMJ OPEN, 2020, 10 (06): : e035087
  • [2] The Care Home Independent Prescribing Pharmacist Study (CHIPPS)—a non-randomised feasibility study of independent pharmacist prescribing in care homes
    Jacqueline Inch
    Frances Notman
    Christine M. Bond
    David P. Alldred
    Antony Arthur
    Annie Blyth
    Amrit Daffu-O’Reilly
    Joanna Ford
    Carmel M. Hughes
    Vivienne Maskrey
    Anna Millar
    Phyo K. Myint
    Fiona M. Poland
    Lee Shepstone
    Arnold Zermansky
    Richard Holland
    David Wright
    [J]. Pilot and Feasibility Studies, 5
  • [3] The Care Home Independent Prescribing Pharmacist Study (CHIPPS)-a non-randomised feasibility study of independent pharmacist prescribing in care homes
    Inch, Jacqueline
    Notman, Frances
    Bond, Christine M.
    Alldred, David P.
    Arthur, Antony
    Blyth, Annie
    Daffu-O'Reilly, Amrit
    Ford, Joanna
    Hughes, Carmel M.
    Maskrey, Vivienne
    Millar, Anna
    Myint, Phyo K.
    Poland, Fiona M.
    Shepstone, Lee
    Zermansky, Arnold
    Holland, Richard
    Wright, David
    [J]. PILOT AND FEASIBILITY STUDIES, 2019, 5 (01)
  • [4] Non-dispensing pharmacist integrated in the primary care team: effect on the quality of physician's prescribing, a non-randomised comparative study
    Sloeserwij, Vivianne M.
    Zwart, Dorien L. M.
    Hazen, Ankie C. M.
    Poldervaart, Judith M.
    Leendertse, Anne J.
    de Bont, Antoinette A.
    Bouvy, Marcel L.
    de Wit, Niek J.
    de Gier, Han J.
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2020, 42 (05) : 1293 - 1303
  • [5] Non-dispensing pharmacist integrated in the primary care team: effect on the quality of physician’s prescribing, a non-randomised comparative study
    Vivianne M. Sloeserwij
    Dorien L. M. Zwart
    Ankie C. M. Hazen
    Judith M. Poldervaart
    Anne J. Leendertse
    Antoinette A. de Bont
    Marcel L. Bouvy
    Niek J. de Wit
    Han J. de Gier
    [J]. International Journal of Clinical Pharmacy, 2020, 42 : 1293 - 1303
  • [6] CARE-HOMES INDEPENDENT PHARMACIST PRESCRIBING STUDY (CHIPPS): EXPERIENCES FROM A NON-RANDOMISED FEASIBILITY STUDY
    Maskrey, V.
    Bond, C.
    Alldred, D. P.
    Blyth, A.
    Daffu-O'Reilly, A.
    Inch, J.
    Millar, A.
    Notman, F.
    Hughes, C.
    Holland, R.
    Wright, D.
    [J]. RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY, 2018, 14 (08): : E26 - E26
  • [7] Prevalence of prescribing in pregnancy using the Irish primary care research network: a pilot study
    Dillon, Paul
    O'Brien, Kirsty K.
    McDonnell, Ronan
    Donnelly-Swift, Erica
    Galvin, Rose
    Roche, Adam
    Cronin, Kate
    Walsh, David R.
    Schelten, Rowan
    Smith, Susan
    Fahey, Tom
    [J]. BMC PREGNANCY AND CHILDBIRTH, 2015, 15
  • [8] Prevalence of prescribing in pregnancy using the Irish primary care research network: a pilot study
    Paul Dillon
    Kirsty K O’Brien
    Ronan McDonnell
    Erica Donnelly-Swift
    Rose Galvin
    Adam Roche
    Kate Cronin
    David R Walsh
    Rowan Schelten
    Susan Smith
    Tom Fahey
    [J]. BMC Pregnancy and Childbirth, 15
  • [9] Supporting prescribing in older people with multimorbidity and significant polypharmacy in primary care (SPPiRE): a cluster randomised controlled trial protocol and pilot
    McCarthy, Caroline
    Clyne, Barbara
    Corrigan, Derek
    Boland, Fiona
    Wallace, Emma
    Moriarty, Frank
    Fahey, Tom
    Hughes, Carmel
    Gillespie, Paddy
    Smith, Susan M.
    [J]. IMPLEMENTATION SCIENCE, 2017, 12
  • [10] Supporting prescribing in older people with multimorbidity and significant polypharmacy in primary care (SPPiRE): a cluster randomised controlled trial protocol and pilot
    Caroline McCarthy
    Barbara Clyne
    Derek Corrigan
    Fiona Boland
    Emma Wallace
    Frank Moriarty
    Tom Fahey
    Carmel Hughes
    Paddy Gillespie
    Susan M. Smith
    [J]. Implementation Science, 12